Coagulation Market Share, Size, and Outlook by 2030
Coagulation Market: Strategic Insights
Coagulation Market
-
CAGR (2022 - 2030)7.0% -
Market Size 2022
US$ 6.3 Billion -
Market Size 2030
US$ 10.85 Billion
Market Dynamics
GROWTH DRIVERS
- Increasing Prevalence of Blood Disorders
- Rising Incidence of Cardiovascular Diseases
FUTURE TRENDS
- Development of Point-of-Care (POC) Coagulation Analyzers
OPPORTUNITIES
- Growing Organic and Inorganic Strategies by Key Market Players
Key Players
- NORDIC BIOMARKER
- ImproGen Diagnostik Kimya San Tic Ltd
- Diagnostica Stago Inc
- Siemens Healthcare Private Limited
- Sysmex
- Helena Biosciences
- F Hoffmann La Roche Ltd
- Genrui Biotech Co Ltd
- Transasia Bio Medicals
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
Disease Indications - Vitamin K Deficiency
- Liver Disease
- Disseminated Intravascular Coagulation & Pulmonary Embolism
- Development of Circulating Anticoagulants
- Hemophilia
- Von Willebrand's Disease
Type - Clinical Laboratory Analyzers
Offering - Diagnosis
- Treatment
Technology - Optical Technology
- Mechanical Technology
- Electrochemical Technology
Get Free Sample For